바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
사전등록 바로가기
 

logo

메뉴
search

ISSN : 0376-4672

논문 상세

이전
논문 투고

47권 8호

Human immunodeficiency virus 감염과 치주 질환의 상관관계, 진단 및 처치에 관한 문헌 고찰

Relationship between human immunodeficiency virus infection and periodontal disease; diagnosis and management strategy

박정철 (연세대학교)
김창성 (연세대학교)
조규성 (연세대학교)
채중규 (연세대학교)
김종관 (연세대학교)
최성호 (연세대학교)
엄유정 (연세대학교)
정의원 (연세대학교)
대한치과의사협회지 / The Journal of the Korean Dental Association, (P)0376-4672; (E)2713-7961
2009, v.47 no.8, pp.522-533
https://doi.org/10.22974/jkda.2009.47.8.006
박정철, 김창성, 조규성, 채중규, 김종관, 최성호, 엄유정, & 정의원. (2009). Human immunodeficiency virus 감염과 치주 질환의 상관관계, 진단 및 처치에 관한 문헌 고찰. 대한치과의사협회지, 47(8), 522-533, https://doi.org/10.22974/jkda.2009.47.8.006

Abstract

Purpose: Infection with HIV-1 virus has become a critical worldwide public health problem. The oral complications of HIV infection with its progression of impairment of the host response to combat infection present unique challenges to the periodontists. Material and Methods : Medline research was carried out to find relationship of the progression of HIV infection to the occurrence of oral lesions including the HIV-related periodontal diseases. Results: The linear gingival erythema, necrotizing ulcerative periodontitis, necrotizing ulcerative gingivitis and oral candidiasis are common lesions in HIV-infected individuals. The linear gingival erythema and necrotizing ulcerative periodontitis lesions in HIV-infected subjects were found to have a similar microbiological profile. There are several general considerations in the periodontal management of the HIV-infected patient with or without periodontal disease. The altered immunity and host response in patients with HIV infection may also affect the incidence and severity of other common forms of periodontal disease not associated with HIV infection. Conclusion: Periodontal diseases in HIV-infected individuals present unique challenges in diagnosis, monitoring, treatment and maintenance. Therefore exact HIV staging, geographic location, antiviral and antimicrobial therapies and oral habits should be taken into consideration when treating HIV-infected patients.

keywords
HIV, AIDS, periodontal disease

참고문헌

1.

1. Piot P, Bartos M, Ghys PD, et al. The global impact of HIV/AIDS. Nature 2001;410:968-73.

2.

2. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. National HIV Prevention Conference Jun 2005.

3.

3. Prevention CfDCa. HIV/AIDS Surveillance Report, 2005. U.S. Department of Health and Human Services 2007.

4.

4. Lee S. The change of route of HIV transmission for the past 11 years in Korea and the projection of the HIV/AIDS cases to the year 2000. Korean J. of Preventive Medicine 1996;29:331-346.

5.

5.질병관리본부. http://www.cdc.go.kr/kcdchome/jsp/home/common/brd/COMMBRD0200Detail.jsp-menuid=100039&boardid=1002&pageNum=0&sub=0&boardseq=21934. 2009.

6.

6. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446-53.

7.

7. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-50.

8.

8. Janssen RS. HIV testing: rationale for changing recommendations. Top HIV Med 2007;15:6-10.

9.

9. Klein D, Hurley LB, Merrill D, Quesenberry CP, Jr. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr 2003;32:143-52.

10.

10. Paltiel AD, Walensky RP, Schackman BR, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med 2006;145:797-806.

11.

11. Beckwith CG, Flanigan TP, del Rio C, et al. It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis 2005;40:1037-40.

12.

12. Patton LL, McKaig R, Strauss R, et al. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:299-304.

13.

13. Ceballos-Salobrena A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS- AIDS Patient Care STDS 2000;14:627-35.

14.

14. Greene VA, Chu SY, Diaz T, Schable B. Oral health problems and use of dental services among HIV-infected adults. Supplement to HIV/AIDS Surveillance Project Group. J Am Dent Assoc 1997;128:1417-22.

15.

15. Greenspan JS. Initiatives in oral acquired immunodeficiency syndrome research. Oral Surg Oral Med Oral Pathol 1992;73:244-7.

16.

16. Ryder MI. Periodontal considerations in the HIV-positive patient. Position paper for the Research science and Therapy Committee 1994.

17.

17. Shine N, Konopka K, Duzgunes N. The anti-HIV-1 activity associated with saliva. J Dent Res 1997;76:634-40.

18.

18. Shine NR, Wang SC, Konopka K, et al. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein. Bioorg Chem 2002;30:249-63.

19.

19. Yin MT, Dobkin JF, Grbic JT. Epidemiology, pathogenesis, and management of human immunodeficiency virus infection in patients with periodontal disease. Periodontol 2000 2007;44:55-81.

20.

20. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.

21.

21. Magierowska M, Theodorou I, Debre P, et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 1999;93:936-41.

22.

22. Gornitsky M, Clark DC, Siboo R, et al. Clinical documentation and occurrence of putative periodontopathic bacteria in human immunodeficiency virus-associated periodontal disease. J Periodontol 1991;62:576-85.

23.

23. Moore LV, Moore WE, Riley C, et al. Periodontal microflora of HIV positive subjects with gingivitis or adult periodontitis. J Periodontol 1993;64:48-56.

24.

24. Zambon JJ, Reynolds HS, Genco RJ. Studies of the subgingival microflora in patients with acquired immunodeficiency syndrome. J Periodontol 1990;61:699-704.

25.

25. Murray PA, Grassi M, Winkler JR. The microbiology of HIVassociated periodontal lesions. J Clin Periodontol 1989;16:636-42.

26.

26. Murray PA, Winkler JR, Peros WJ, et al. DNA probe detection of periodontal pathogens in HIV-associated periodontal lesions. Oral Microbiol Immunol 1991;6:34-40.

27.

27. Alpagot T, Duzgunes N, Wolff LF, Lee A. Risk factors for periodontitis in HIV patients. J Periodontal Res 2004;39:149-57.

28.

28. Baqui AA, Meiller TF, Jabra-Rizk MA, et al. Enhanced interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in gingival crevicular fluid from periodontal pockets of patients infected with human immunodeficiency virus 1. Oral Microbiol Immunol 2000;15:67-73.

29.

29. Steinsvoll S, Myint M, Odden K, et al. Reduced serum IgG reactivities with bacteria from dental plaque in HIV-infected persons with periodontitis. J Clin Periodontol 1997;24:823-9.

30.

30. Mardirossian A, Contreras A, Navazesh M, et al. Herpesviruses 6, 7 and 8 in HIV- and non-HIV-associated periodontitis. J Periodontal Res 2000;35:278-84.

31.

31. Schiodt M, Pindborg JJ. AIDS and the oral cavity. Epidemiology and clinical oral manifestations of human immune deficiency virus infection: a review. Int J Oral Maxillofac Surg 1987;16:1-14.

32.

32. Holmstrup P. Non-plaque-induced gingival lesions. Ann Periodontol 1999;4:20-31.

33.

33. Grbic JT, Mitchell-Lewis DA, Fine JB, et al. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. J Periodontol 1995;66:30-7.

34.

34. Gomez RS, da Costa JE, Loyola AM, et al. Immunohistochemical study of linear gingival erythema from HIV-positive patients. J Periodontal Res 1995;30:355-9.

35.

35. Odden K, Schenck K, Koppang H, Hurlen B. Candidal infection of the gingiva in HIV-infected persons. J Oral Pathol Med 1994;23:178-83.

36.

36. Drinkard CR, Decher L, Little JW, et al. Periodontal status of individuals in early stages of human immunodeficiency virus infection. Community Dent Oral Epidemiol 1991;19:281-5.

37.

37. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:182-8.

38.

38. Williams CA, Winkler JR, Grassi M, Murray PA. HIV-associated periodontitis complicated by necrotizing stomatitis. Oral Surg Oral Med Oral Pathol 1990;69:351-5.

39.

39. Glick M, Cleveland DB, Salkin LM, et al. Intraoral cytomegalovirus lesion and HIV-associated periodontitis in a patient with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1991;72:716-20.

40.

40. Dodd CL, Winkler JR, Heinic GS, et al. Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodeficiency virus. J Clin Periodontol 1993;20:282-5.

41.

41. Barr C, Lopez MR, Rua-Dobles A. Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. J Clin Periodontol 1992;19:794-801.

42.

42. Swango PA, Kleinman DV, Konzelman JL. HIV and periodontal health. A study of military personnel with HIV. J Am Dent Assoc 1991;122:49-54.

43.

43. Friedman RB, Gunsolley J, Gentry A, et al. Periodontal status of HIV-seropositive and AIDS patients. J Periodontol 1991;62:623-7.

44.

44. Lucht E, Heimdahl A, Nord CE. Periodontal disease in HIVinfected patients in relation to lymphocyte subsets and specific micro-organisms. J Clin Periodontol 1991;18:252-6.

45.

45. Yeung SC, Stewart GJ, Cooper DA, Sindhusake D. Progression of periodontal disease in HIV seropositive patients. J Periodontol 1993;64:651-7.

46.

46. Lamster IB, Grbic JT, Mitchell-Lewis DA, et al. New concepts regarding the pathogenesis of periodontal disease in HIV infection. Ann Periodontol 1998;3:62-75.

47.

47. Roberts MW, Brahim JS, Rinne NF. Oral manifestations of AIDS: a study of 84 patients. J Am Dent Assoc 1988;116:863-6.

48.

48. Matee M, Nguvumali H, Lembariti B, et al. HIV infection, dental treatment demands and needs among patients seeking dental services at the Muhimbili Medical Centre in Dar-es-Salaam, Tanzania. Int Dent J 1999;49:153-8.

49.

49. Scheutz F, Matee MI, Andsager L, et al. Is there an association between periodontal condition and HIV infection- J Clin Periodontol 1997;24:580-7.

50.

50. Smith GL, Cross DL, Wray D. Comparison of periodontal disease in HIV seropositive subjects and controls (I). Clinical features. J Clin Periodontol 1995;22:558-68.

51.

51. Martinez-Canut P, Guarinos J, Bagan JV. Periodontal disease in HIV seropositive patients and its relation to lymphocyte subsets. J Periodontol 1996;67:33-6.

52.

52. Maticic M, Poljak M, Kramar B, et al. Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease. J Dent Res 2000;79:1496-501.

53.

53. Ndiaye CF, Critchlow CW, Leggott PJ, et al. Periodontal status of HIV-1 and HIV-2 seropositive and HIV seronegative female commercial sex workers in Senegal. J Periodontol 1997;68:827-31.

54.

54. Kinane DF. Periodontitis modified by systemic factors. Ann Periodontol 1999;4:54-64.

55.

55. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.

56.

56. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-9.

57.

57. Glick M, Muzyka BC, Salkin LM, Lurie D. Necrotizing ulcerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol 1994;65:393-7.

58.

58. Ceballos-Salobrena A, Aguirre-Urizar JM, Bagan-Sebastian JV. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med 1996;25:523-6.

59.

59. Ficarra G, Berson AM, Silverman S, Jr., et al. Kaposi’s sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment. Oral Surg Oral Med Oral Pathol 1988;66:543-50.

60.

60. Reichart PA, Gelderblom HR, Becker J, Kuntz A. AIDS and the oral cavity. The HIV-infection: virology, etiology, origin, immunology, precautions and clinical observations in 110 patients. Int J Oral Maxillofac Surg 1987;16:129-53.

61.

61. Scully C, Laskaris G, Pindborg J, et al. Oral manifestations of HIV infection and their management. I. More common lesions. Oral Surg Oral Med Oral Pathol 1991;71:158-66.

62.

62. Winkler JR, Robertson PB. Periodontal disease associated with HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:145-50.

63.

63. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991;5:519-25.

64.

64. Phelan JA, Saltzman BR, Friedland GH, Klein RS. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1987;64:50-6.

65.

65. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993;22:289-91.

66.

66. Ryder MI, Winkler JR, Weinreb RN. Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection. J Acquir Immune Defic Syndr 1988;1:346-53.

67.

67. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi’ s sarcoma and non-Hodgkin’s lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 1999;319:23-4.

68.

68. Greenspan D, Greenspan JS, Hearst NG, et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 1987;155:475-81.

69.

69. Winkler JR, Murray PA, Grassi M, Hammerle C. Diagnosis and management of HIV-associated periodontal lesions. J Am Dent Assoc 1989;Suppl:25S-34S.

70.

70. Schulten EA, ten Kate RW, van der Waal I. Oral manifestations of HIV infection in 75 Dutch patients. J Oral Pathol Med 1989;18:42-6.

71.

71. Robinson PG. Treatment of HIV-associated periodontal diseases. Oral Dis 1997;3 Suppl 1:S238-40.

72.

72. Robinson PG. Which periodontal changes are associated with HIV infection- J Clin Periodontol 1998;25:278-85.

73.

73. Palmer GD, Morgan PR, Challacombe SJ. T-cell lymphoma associated with periodontal disease and HIV infection. A case report. J Clin Periodontol 1993;20:378-80.

74.

74. Patton LL, McKaig R. Rapid progression of bone loss in HIVassociated necrotizing ulcerative stomatitis. J Periodontol 1998;69:710-6.

75.

75. Munro CA, Hube B. Anti-fungal therapy at the HAART of viral therapy. Trends Microbiol 2002;10:173-7.

76.

76. Lucartorto FM, Franker CK, Maza J. Postscaling bacteremia in HIV-associated gingivitis and periodontitis. Oral Surg Oral Med Oral Pathol 1992;73:550-4.

77.

77. Lifson AR. Do alternate modes for transmission of human immunodeficiency virus exist- A review. JAMA 1988;259:1353-6.

78.

78. McCray E. Occupational risk of the acquired immunodeficiency syndrome among health care workers. N Engl J Med 1986;314:1127-32.

79.

79. Gerberding JL, Bryant-LeBlanc CE, Nelson K, et al. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 1987;156:1-8.

80.

80. Klein RS, Phelan JA, Freeman K, et al. Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med 1988;318:86-90.

81.

81. Schneider DA, Hardwick KS, Marconi KM, et al. Delivery of oral health care through the Ryan White CARE Act to people infected with HIV. J Public Health Dent 1993;53:258-64.

82.

82. Smith GL, Felix DH, Wray D. Current classifications of HIVassociated periodontal diseases. Br Dent J 1993;174:102-5.

83.

83. Yeung SC, Kazazi F, Randle CG, et al. Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis 1993;167:803-9.

84.

84. Suzuki T, Tai H, Yoshie H, et al. Characterization of HIV-related periodontitis in AIDS patients: HIV-infected macrophage exudate in gingival crevicular fluid as a hallmark of distinctive etiology. Clin Exp Immunol 1997;108:254-9.

85.

85. Suzuki T, Yoshie H, Jeannel D, et al. Detection of intracellular p24-positive macrophages in gingival crevicular fluid from periodontal lesions of stage IV AIDS patients. AIDS 1996;10:804-5.

logo

논문 투고
OA 정책